Cargando…

Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide

BACKGROUND: Shifts in data sharing policy have increased researchers’ access to individual participant data (IPD) from clinical studies. Simultaneously the number of IPD meta-analyses (IPDMAs) is increasing. However, rates of data retrieval have not improved. Our goal was to describe the challenges...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventresca, Matthew, Schünemann, Holger J., Macbeth, Fergus, Clarke, Mike, Thabane, Lehana, Griffiths, Gareth, Noble, Simon, Garcia, David, Marcucci, Maura, Iorio, Alfonso, Zhou, Qi, Crowther, Mark, Akl, Elie A., Lyman, Gary H., Gloy, Viktoria, DiNisio, Marcello, Briel, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218569/
https://www.ncbi.nlm.nih.gov/pubmed/32398016
http://dx.doi.org/10.1186/s12874-020-00964-6
_version_ 1783532825540034560
author Ventresca, Matthew
Schünemann, Holger J.
Macbeth, Fergus
Clarke, Mike
Thabane, Lehana
Griffiths, Gareth
Noble, Simon
Garcia, David
Marcucci, Maura
Iorio, Alfonso
Zhou, Qi
Crowther, Mark
Akl, Elie A.
Lyman, Gary H.
Gloy, Viktoria
DiNisio, Marcello
Briel, Matthias
author_facet Ventresca, Matthew
Schünemann, Holger J.
Macbeth, Fergus
Clarke, Mike
Thabane, Lehana
Griffiths, Gareth
Noble, Simon
Garcia, David
Marcucci, Maura
Iorio, Alfonso
Zhou, Qi
Crowther, Mark
Akl, Elie A.
Lyman, Gary H.
Gloy, Viktoria
DiNisio, Marcello
Briel, Matthias
author_sort Ventresca, Matthew
collection PubMed
description BACKGROUND: Shifts in data sharing policy have increased researchers’ access to individual participant data (IPD) from clinical studies. Simultaneously the number of IPD meta-analyses (IPDMAs) is increasing. However, rates of data retrieval have not improved. Our goal was to describe the challenges of retrieving IPD for an IPDMA and provide practical guidance on obtaining and managing datasets based on a review of the literature and practical examples and observations. METHODS: We systematically searched MEDLINE, Embase, and the Cochrane Library, until January 2019, to identify publications focused on strategies to obtain IPD. In addition, we searched pharmaceutical websites and contacted industry organizations for supplemental information pertaining to recent advances in industry policy and practice. Finally, we documented setbacks and solutions encountered while completing a comprehensive IPDMA and drew on previous experiences related to seeking and using IPD. RESULTS: Our scoping review identified 16 articles directly relevant for the conduct of IPDMAs. We present short descriptions of these articles alongside overviews of IPD sharing policies and procedures of pharmaceutical companies which display certification of Principles for Responsible Clinical Trial Data Sharing via Pharmaceutical Research and Manufacturers of America or European Federation of Pharmaceutical Industries and Associations websites. Advances in data sharing policy and practice affected the way in which data is requested, obtained, stored and analyzed. For our IPDMA it took 6.5 years to collect and analyze relevant IPD and navigate additional administrative barriers. Delays in obtaining data were largely due to challenges in communication with study sponsors, frequent changes in data sharing policies of study sponsors, and the requirement for a diverse skillset related to research, administrative, statistical and legal issues. CONCLUSIONS: Knowledge of current data sharing practices and platforms as well as anticipation of necessary tasks and potential obstacles may reduce time and resources required for obtaining and managing data for an IPDMA. Sufficient project funding and timeline flexibility are pre-requisites for successful collection and analysis of IPD. IPDMA researchers must acknowledge the additional and unexpected responsibility they are placing on corresponding study authors or data sharing administrators and should offer assistance in readying data for sharing.
format Online
Article
Text
id pubmed-7218569
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72185692020-05-18 Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide Ventresca, Matthew Schünemann, Holger J. Macbeth, Fergus Clarke, Mike Thabane, Lehana Griffiths, Gareth Noble, Simon Garcia, David Marcucci, Maura Iorio, Alfonso Zhou, Qi Crowther, Mark Akl, Elie A. Lyman, Gary H. Gloy, Viktoria DiNisio, Marcello Briel, Matthias BMC Med Res Methodol Research Article BACKGROUND: Shifts in data sharing policy have increased researchers’ access to individual participant data (IPD) from clinical studies. Simultaneously the number of IPD meta-analyses (IPDMAs) is increasing. However, rates of data retrieval have not improved. Our goal was to describe the challenges of retrieving IPD for an IPDMA and provide practical guidance on obtaining and managing datasets based on a review of the literature and practical examples and observations. METHODS: We systematically searched MEDLINE, Embase, and the Cochrane Library, until January 2019, to identify publications focused on strategies to obtain IPD. In addition, we searched pharmaceutical websites and contacted industry organizations for supplemental information pertaining to recent advances in industry policy and practice. Finally, we documented setbacks and solutions encountered while completing a comprehensive IPDMA and drew on previous experiences related to seeking and using IPD. RESULTS: Our scoping review identified 16 articles directly relevant for the conduct of IPDMAs. We present short descriptions of these articles alongside overviews of IPD sharing policies and procedures of pharmaceutical companies which display certification of Principles for Responsible Clinical Trial Data Sharing via Pharmaceutical Research and Manufacturers of America or European Federation of Pharmaceutical Industries and Associations websites. Advances in data sharing policy and practice affected the way in which data is requested, obtained, stored and analyzed. For our IPDMA it took 6.5 years to collect and analyze relevant IPD and navigate additional administrative barriers. Delays in obtaining data were largely due to challenges in communication with study sponsors, frequent changes in data sharing policies of study sponsors, and the requirement for a diverse skillset related to research, administrative, statistical and legal issues. CONCLUSIONS: Knowledge of current data sharing practices and platforms as well as anticipation of necessary tasks and potential obstacles may reduce time and resources required for obtaining and managing data for an IPDMA. Sufficient project funding and timeline flexibility are pre-requisites for successful collection and analysis of IPD. IPDMA researchers must acknowledge the additional and unexpected responsibility they are placing on corresponding study authors or data sharing administrators and should offer assistance in readying data for sharing. BioMed Central 2020-05-12 /pmc/articles/PMC7218569/ /pubmed/32398016 http://dx.doi.org/10.1186/s12874-020-00964-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ventresca, Matthew
Schünemann, Holger J.
Macbeth, Fergus
Clarke, Mike
Thabane, Lehana
Griffiths, Gareth
Noble, Simon
Garcia, David
Marcucci, Maura
Iorio, Alfonso
Zhou, Qi
Crowther, Mark
Akl, Elie A.
Lyman, Gary H.
Gloy, Viktoria
DiNisio, Marcello
Briel, Matthias
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title_full Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title_fullStr Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title_full_unstemmed Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title_short Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
title_sort obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218569/
https://www.ncbi.nlm.nih.gov/pubmed/32398016
http://dx.doi.org/10.1186/s12874-020-00964-6
work_keys_str_mv AT ventrescamatthew obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT schunemannholgerj obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT macbethfergus obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT clarkemike obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT thabanelehana obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT griffithsgareth obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT noblesimon obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT garciadavid obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT marcuccimaura obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT iorioalfonso obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT zhouqi obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT crowthermark obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT akleliea obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT lymangaryh obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT gloyviktoria obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT dinisiomarcello obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide
AT brielmatthias obtainingandmanagingdatasetsforindividualparticipantdatametaanalysisscopingreviewandpracticalguide